TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

101.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

GeneDx Holdings Corp. (WGS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 570 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WGS
Line item 2019 2020 2021 2022 2023 2024 2025
252 554 545 419 419 570
164 174 484 213 182 198 268
108 401 137 100 85 105
108 401 137 130 141 171
22 32 27 43 33 38 74
16 25 33 14 8.8 11 14
35 63 63 84
0.0 14
187 173 159 168
247 166 292 191 174 262
40 73 101 144 59 55 109
3.5 3.4 11 4.1 3.3 8.9
17 27 45 46 10 8.0 2.5
19 11 6.3 53 52 48
4.4 388 254 228 245 308
-89 -330 -575 -1,124 -1,300 -1,352 -1,373
5.6 5.6 3.3 10 24 27 27

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?